These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7478098)

  • 1. [Parkinson syndrome induced by veralipride].
    Franchignoni FP; Tesio L
    Minerva Ginecol; 1995 Jun; 47(6):277-9. PubMed ID: 7478098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.
    Teive HA; Sa DS
    Arq Neuropsiquiatr; 2001 Mar; 59(1):123-4. PubMed ID: 11299446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
    Masmoudi K; Gras-Champel V; Lemaire-Hurtel AS; Masson H; Munier A; Geslin JM; Andréjak M
    Rev Med Interne; 2005 Jun; 26(6):453-7. PubMed ID: 15936474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiratory dyskinesia induced by veralipride].
    Marta-Moreno E; Gracia-Naya M; Marzo-Sola ME
    Rev Neurol; 1997 Feb; 25(138):245-7. PubMed ID: 9147748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
    Masmoudi K; Decocq G; Chetaille E; Rosa A; Mizon JP; Andréjak M
    Therapie; 1995; 50(5):451-4. PubMed ID: 8571284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
    Verbeke K; Dhont M; Vandekerckhove D
    Maturitas; 1988 Oct; 10(3):225-30. PubMed ID: 3185294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actual status of veralipride use.
    Carranza-Lira S
    Clin Interv Aging; 2010 Sep; 5():271-6. PubMed ID: 20852674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
    Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Moggi L; Fioretti P
    J Clin Endocrinol Metab; 1988 May; 66(5):964-7. PubMed ID: 2834413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
    Carretti N; Florio P; Reis FM; Comai S; Bertazzo A; Petraglia F
    Climacteric; 2010 Apr; 13(2):141-6. PubMed ID: 20082603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Veralipride and menopause].
    Laffargue F; Viala JL; Durand G
    Sem Hop; 1983 Sep; 59(29-30):2127-30. PubMed ID: 6312585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.
    Montemurro D; Rossi GP
    J Endocrinol Invest; 2006; 29(7):650-2. PubMed ID: 16957415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance to veralipride administered for an extended time].
    Milliez J
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):27-8, 31. PubMed ID: 6531585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Veralipride in the treatment of hot flushes in the menopause].
    Pasetto N; Piccione E; Baschieri L
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):163-5. PubMed ID: 3922035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of veralipride.
    De Leo V; Morgante G; Musacchio MC; Faldini E; Delia A; Petraglia F
    Expert Opin Drug Saf; 2006 Sep; 5(5):695-701. PubMed ID: 16907659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
    Dargent D; Dumont M; Malinas Y
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):171-3. PubMed ID: 3992114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veralipride-induced tardive dystonia in a patient with bipolar psychosis.
    Gabellini AS; Pezzoli A; De Massis P; Sacquegna T
    Ital J Neurol Sci; 1992 Oct; 13(7):621-3. PubMed ID: 1428799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.